Ocular Vaccinia Infection in Dairy Worker, Brazil

We studied a clinical case of vaccinia virus that caused an ocular manifestation in a dairy worker in Brazil. Biologic and molecular analyses identified a co-infection with 2 isolates from different Brazilian vaccinia virus phylogenetic groups.

We studied a clinical case of vaccinia virus that caused an ocular manifestation in a dairy worker in Brazil. Biologic and molecular analyses identified a co-infection with 2 isolates from different Brazilian vaccinia virus phylogenetic groups.

D etection of co-infections for various viral pathogens
recently has increased (1,2). However, the presence of >2 viral etiologic agents often is not considered (1). The range of pathogens that can present co-infections and the association of these infections with the occurrence and severity of disease remain unclear (1,2). Vaccinia virus (VACV), the prototype virus of the genus Orthopoxvirus, has been associated with exanthematic outbreaks in Asia and South America that affect mainly dairy cattle and rural workers (3,4). In Brazil, several Brazilian VACV (VACV-BR) have been isolated and characterized biologically and phylogenetically. These studies demonstrated that circulating viruses belonged to at least 2 distinct genetic clusters (4)(5)(6)(7)(8). Previous studies have demonstrated the co-circulation of distinct VACV isolates during the same outbreak and VACV co-infecting horses and cattle (6)(7)(8).
We obtained 2 distinct VACV isolates from the same clinical sample from 1 eye of a rural worker. Our data show that the eye was co-infected with 2 VACV and demonstrates the detection and isolation of VACV from a natural case of ocular vaccinia infection.
In Dried swab specimens from his lesions were soaked in 200 µL phosphate-buffered saline containing amphotericin B (4 µg/mL), penicillin (200 U/mL), and streptomycin (100 µg/mL); homogenized; and centrifuged at 3,000 × g for 5 min (4). The supernatants were used for molecular diagnosis using orthopoxvirus-specific PCR that targeted the C11R gene, which encodes viral growth factor, and the A56R gene, which encodes viral hemagglutinin protein (4). All samples were positive for both orthopoxvirus targets.
Vero cells were cultured in 25-cm 2 culture flasks and infected with the specimen supernatants to isolate the virus at 37°C until a cytopathic effect was detected (4). VACV was isolated from the hand, nose, and eye samples. These isolates were tested for their plaque phenotypes in BSC-40 cells incubated at 37°C for 48 h (4), which demonstrated the presence of at least 2 types of viral populations comprising small and large plaques in an estimated ratio 2:1. Two viral plaques (1 forming large and 1 forming small plaques) were obtained from the eye sample after 3 additional rounds of plaque purification in BSC-40 cells (online Technical Appendix Figure, panel B) (4). The viral plaques were propagated and titrated by plaque assay in Vero cells, and their DNA was extracted (4).
We obtained the complete genomes using the Illumina MiSeq instrument (Illumina, San Diego, CA, USA) with the paired-end application. The sequence reads were assembled de novo using ABYSS software (http://www.bcgsc.ca/platform/bioinfo/software/abyss), and the resulting contigs were ordered by the python-based CONTIGuator.py software (http://contiguator.sourceforge.net). The GenBank accession numbers are MG012795 (small) and MG012796 (large).
Analysis of the complete genome revealed 92% similarity between the 2 isolates, and some genes confirm a remarkable variability (online Technical Appendix Figure, panel C). We constructed a phylogenetic tree (online Technical Appendix Figure, panel D) using the A56R gene sequence by the maximum-likelihood method and 1,000 bootstrap replicates in MEGA 6.02 (http://www.megasoftware.net). The analysis demonstrated a co-infection with viruses from both VACV-BR groups, such that the large-plaque clone clustered with group 2 VACV-BR isolates and the small-plaque clone clustered with group 1 VACV-BR isolates. We named these isolates Carangola eye virus 1 (small) and Carangola eye virus 2 (large).
Our study demonstrated the genetic and phenotypic variability between 2 viruses isolated from the same sample in a natural human co-infection with VACV. The viruses belong to 2 distinct VACV-BR groups, reinforcing and expanding previous work with other hosts (6)(7)(8). These results raise new questions about how co-infections with these viruses might change the aspects of an infection and its signs and symptoms, such as development of ocular vaccinia. Although cases of ocular vaccinia have been reported after vaccination and accidental laboratory infection (9,10), we proved the association and isolate VACV samples from a natural ocular vaccinia infection. The effort to understand singular aspects of VACV-BR co-infections should be increased, and further molecular and biologic characterizations of these samples should be conducted to identify and better understand the natural dynamics and signs and symptoms caused by VACV-BR.